A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction
Clinical trial NCT04661150 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04661150
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2023-05-08
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.